Clinical Report: A Framework for Understanding Information Dysregulation in Addiction

Overview

The Informational Dysregulation Framework of Addiction (IDFA) offers a perspective on relapse vulnerability in opioid use disorder (OUD) by integrating concepts from neuroscience, computational psychiatry, and clinical relapse research. It emphasizes the role of information processing in understanding relapse risk.

Background

Opioid use disorder is a significant public health issue characterized by high rates of relapse. Understanding the mechanisms behind relapse is crucial. The IDFA aims to bridge the gap between neurobiological insights and clinical practice, providing a structured approach to address relapse vulnerability.

Data Highlights

No numerical data or trial data available in the source material.

Key Findings

• The IDFA conceptualizes relapse vulnerability as a dysregulation in how the brain processes information under uncertainty.
• Relapse processes are organized into three domains: precision dysregulation, entropy and complexity disruption, and awareness and integration impairment.
• These processes create a self-reinforcing loop that limits behavioral flexibility and narrows informational bandwidth.
• The framework integrates established models of reward learning and habit formation with an information-processing perspective.
• IDFA generates hypotheses for relapse prediction and intervention planning across treatment modalities.

Clinical Implications

The IDFA provides a framework for understanding the cognitive and behavioral aspects of relapse in OUD.

Conclusion

The Informational Dysregulation Framework of Addiction offers a model for understanding the complexities of relapse in opioid use disorder.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Best Practices for Hospital-Based Initiation of Medications for Opioid Use Disorder: A Consensus Statement - PubMed
6. WHO’s new guidance on maintaining opioid agonist maintenance treatment as an essential health service
7. Linking People with Opioid Use Disorder to Medication Treatment | Overdose Prevention | CDC
8. Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use: A Randomized Clinical Trial | JAMA Network
9. Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine: A Randomized Clinical Trial | JAMA Network
10. Buprenorphine-naloxone vs methadone for opioid use disorder: a systematic review and meta-analysis of randomized clinical trials - PubMed
11. Factors associated with the percentage of individuals who initiate and discontinue naltrexone as a relapse prevention pharmacotherapy in opioid use disorder: A systematic review, meta-analysis and meta-regression - PubMed
12. Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis - PubMed
13. Best Practices for Hospital-Based Initiation of Medications for Opioid Use Disorder: A Consensus Statement - PubMed
14. WHO’s new guidance on maintaining opioid agonist maintenance treatment as an essential health service
15. Linking People with Opioid Use Disorder to Medication Treatment | Overdose Prevention | CDC
16. Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use: A Randomized Clinical Trial | Pharmacy and Clinical Pharmacology | JAMA Network Open | JAMA Network
17. Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine: A Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA Network Open | JAMA Network
18. Buprenorphine-naloxone vs methadone for opioid use disorder: a systematic review and meta-analysis of randomized clinical trials - PubMed
19. Factors associated with the percentage of individuals who initiate and discontinue naltrexone as a relapse prevention pharmacotherapy in opioid use disorder: A systematic review, meta-analysis and meta-regression - PubMed
20. Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-Analysis - PubMed